Custom Lucite, incorporating an embedded vial, celebrating the first-in-human dosing in a Phase 1 clinical trial of cancer treatment developed by biotech company Immunome. (25ALJ040)
Custom Lucite, incorporating an embedded vial, celebrating the first-in-human dosing in a Phase 1 clinical trial of cancer treatment developed by biotech company Immunome. (25ALJ040)
Custom Lucite celebrating the approval by the U.S. Food and Drug Administration (FDA) of the drug Crenessity. Crenessity was developed by Neurocrine Biosciences to treat a rare congenital adrenal condition. (25ALJ020)
Logo-themed crystal financial tombstone commemorating a follow-on stock offering by Palisade Bio. The biopharmaceutical firm is based in Carlsbad, California. (25AKL019)
Custom crystal deal toy marking an investment in GXP-Storage. The Raleigh, North Carolina-based company provides storage for materials for life sciences and biomedical research. (25AZH003)
Custom Lucite deal toy, replicating a spray bottle product, commemorating a follow-on stock offering by Novabay Pharmaceuticals. The Emeryville, California-based biopharmaceutical company develops products for the eye care market. (24AKL343)
Crystal deal toy commmemorating a private placement for biopharmaceutical firm Palisade Bio. (24AKL340)
Crystal deal toy recognizing a follow-on public stock offering by Autonomix Medical. The Texas-based company specializes in technologies aimed at diagnosing and treating diseases involving the nervous systems. (24AKL507)
Custom Lucite celebrating the first-in-human trial of SOR 102, a treatment for nflammatory bowel disease. The drug was developed by Utah-based Sorriso Pharmaceuticals. (23AKL435)
Crystal financial tombstone celebrating Series B financing for Nuvig Therapeutics. The immune drug developer is based in Menlo Park, California. (24ALJ345)
